Cited by 357Advanced Drug Delivery SystemsBarrier Structure and Function StudiesNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 217 of the 219 references it cites were found in a registry or an index.

Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics

Open access

Bourganis, Vassilis, Kammona, Olga, Alexopoulos, Aleck, Kiparissides, Costas·2018·European Journal of Pharmaceutics and Biopharmaceutics

DOI 10.1016/j.ejpb.2018.05.009

Open this paper in CoChat — free account Open PDF

Abstract

Central nervous system (CNS) disorders (e.g., multiple sclerosis, Alzheimer's disease, etc.) represent a growing public health issue, primarily due to the increased life expectancy and the aging population. The treatment of such disorders is notably elaborate and requires the delivery of therapeutics to the brain in appropriate amounts to elicit a pharmacological response. However, despite the major advances both in neuroscience and drug delivery research, the administration of drugs to the CNS still remains elusive. It is commonly accepted that effectiveness-related issues arise due to the inability of parenterally administered macromolecules to cross the Blood-Brain Barrier (BBB) in order to access the CNS, thus impeding their successful delivery to brain tissues. As a result, the direct Nose-to-Brain delivery has emerged as a powerful strategy to circumvent the BBB and deliver drugs to the brain. The present review article attempts to highlight the different experimental and computational approaches pursued so far to attain and enhance the direct delivery of therapeutic agents to the brain and shed some light on the underlying mechanisms involved in the pathogenesis and treatment of neurological disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ejpb.2018.05.009

Cites

217 of 217 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 3,109
Macromolecular Crowding and Confinement: Biochemical, Biophysical, and Potential Physiological Consequences
Zhou, H., Rivas, G., & Minton, A. P. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125817 · Cited by 2,160
Nanoemulsions versus microemulsions: terminology, differences, and similarities
McClements, D. J. (2011) · Soft Matter · doi:10.1039/c2sm06903b · Cited by 1,786
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,494
Barrier properties of mucus
Cone, R. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.
Abuchowski, A., Es, T. V., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review
Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.049 · Cited by 1,293
Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.
Abuchowski, A., McCoy, J. R., Palczuk, N. C., Es, T. V., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,276
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,256

Show all 219 references

Research works printed but not linked: 5

M. Dahlin, Nasal administration of compounds active in the Central Nervous System - Exploring the olfactory pathway, Uppsala University, Ph.D Dissertation, (2000).
V. Dhamankar, Cytochrome P450-mediated drug metabolizing activity in the nasal mucosa, The University of Iowa, Ph.D Dissertation, 2013.
Pardeshi, 2015, Novel nasal devices for the efficient drug delivery: A systemic review, Indian J. Nov. Drug Deliv., 7, 1
A. Mistry, The development and application of biological models for evaluation of direct nose-to-brain drug delivery systems. Ph.D Dissertation, University of Nottingham, (2009).
K. Inthavong, K. Zhang, J. Tu, Modelling submicron and micron particle deposition in a human nasal cavity, Seventh International Conference on CFD in the Minerals and Process Industries, CSIRO, Melbourne, Australia, 2009.

Sorted by citations

Items 101–200 of 357

Biomaterials for Drugs Nose–Brain Transport: A New Therapeutic Approach for Neurological Diseases
Cassano, R., Servidio, C., & Trombino, S. (2021) · Materials · doi:10.3390/ma14071802 · Cited by 40
Synchronizing In Silico , In Vitro , and In Vivo Studies for the Successful Nose to Brain Delivery of an Anticancer Molecule
Abd-algaleel, S. A., Metwally, A. A., Abdel‐Bar, H. M., Kassem, D. H., & Hathout, R. M. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00276 · Cited by 39
Mitochondrial sensitive probe with aggregation‐induced emission characteristics for early brain diagnosis of Parkinson's disease
Huang, L., Zhou, Y., Jiao, D., Ren, J., Qi, Y., Wang, H., Shi, Y., Ding, D., & Xue, X. (2023) · Aggregate · doi:10.1002/agt2.403 · Cited by 38
Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review
Kulkarni, M., Patel, K., Patel, A. K., Patel, S., Desai, J. L., Patel, M. M., Shah, U., Patel, A. D., & Solanki, N. D. (2023) · ADMET & DMPK · doi:10.5599/admet.2043 · Cited by 46
Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS
Sarma, A., & Das, M. K. (2020) · Molecular Biomedicine · doi:10.1186/s43556-020-00019-8 · Cited by 39
Oxidized Alginate Dopamine Conjugate: In Vitro Characterization for Nose-to-Brain Delivery Application
Trapani, A., Corbo, F., Agrimi, G., Ditaranto, N., Cioffi, N., Perna, F. M., Quivelli, A. F., Stefàno, E., Lunetti, P., Muscella, A., et al. (2021) · Materials · doi:10.3390/ma14133495 · Cited by 37
Investigation of the Transport Pathways Associated with Enhanced Brain Delivery of Peptide Drugs by Intranasal Coadministration with Penetratin
Kamei, N., Suwabe, S., Arime, K., Bando, H., Murata, K., Yamaguchi, M., Yokoyama, N., Tanaka, E., Hashimoto, A., Kanazawa, T., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111745 · Cited by 38
Thin film hydration versus modified spraying technique to fabricate intranasal spanlastic nanovesicles for rasagiline mesylate brain delivery: Characterization, statistical optimization, and in vivo pharmacokinetic evaluation
Ali, M. M., Shoukri, R. A., & Yousry, C. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01285-5 · Cited by 36
In-depth Mechanism, Challenges, and Opportunities of Delivering Therapeutics in Brain Using Intranasal Route
Ghosh, A., Majie, A., Karmakar, V., Chatterjee, K., Chakraborty, S., Pandey, M., Jain, N., Sarkar, S. R., Nair, A. B., & Gorain, B. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02810-0 · Cited by 40
Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery?
Ladel, S., Flamm, J., Zadeh, A. S., Filzwieser, D., Walter, J.-C., Schlossbauer, P., Kinscherf, R., Lischka, K., Luksch, H., & Schindowski, K. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030107 · Cited by 36
Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review
Moradi, F., & Dashti, N. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02196-x · Cited by 37
Computational, In Vitro, and In Vivo Models for Nose-to-Brain Drug Delivery Studies
Boyuklieva, R., Zagorchev, P. I., & Pilicheva, B. (2023) · Biomedicines · doi:10.3390/biomedicines11082198 · Cited by 38
Neuroprotective effect of nose-to-brain delivery of Asiatic acid in solid lipid nanoparticles and its mechanisms against memory dysfunction induced by Amyloid Beta1-42 in mice
Islamie, R., Myint, S. L. L., Rojanaratha, T., Ritthidej, G. C., Wanakhachornkrai, O., Wattanathamsan, O., & Rodsiri, R. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04125-2 · Cited by 35
Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease
Singh, S., & Shukla, R. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02625-5 · Cited by 35
Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson’s disease treatment?
Rehman, S., Nabi, B., Zafar, A., Baboota, S., & Ali, J. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1684895 · Cited by 37
Dopamine-loaded lipid based nanocarriers for intranasal administration of the neurotransmitter: A comparative study
Trapani, A., Giglio, E. D., Cometa, S., Bonifacio, M. A., Dazzi, L., Gioia, S. D., Hossain, M. N., Pellitteri, R., Antimisiaris, S. G., & Conese, M. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.07.015 · Cited by 35
Nanocarrier-Based Approaches to Combat Chronic Obstructive Pulmonary Disease
Virmani, T., Kumar, G., Virmani, R., Sharma, A., & Pathak, K. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0403 · Cited by 35
The liquid crystalline phase behaviour of a nasal formulation modifies the brain disposition of donepezil in rats in the treatment of Alzheimer's disease
de Souza, I. F. F., dos Santos, T. Q., Plácido, R. V., Mangerona, B. A., Carvalho, F. C., Boralli, V. B., Ruela, A. L. M., & Pereira, G. R. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.111721 · Cited by 34
Targeting nanoparticles to malignant tumors
Sharma, N., Bietar, K., & Stochaj, U. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188703 · Cited by 36
Enhanced Intranasal Delivery of Atorvastatin via Superparamagnetic Iron-Oxide-Loaded Nanocarriers: Cytotoxicity and Inflammation Evaluation and In Vivo, In Silico, and Network Pharmacology Study for Targeting Glioblastoma Management
Attalla, K. Z., Hassan, D. H., Teaima, M. H. M., Yousry, C., El-Nabarawi, M. A., Said, M. A., & Elhabal, S. F. (2025) · Pharmaceuticals · doi:10.3390/ph18030421 · Cited by 32
Novel Nanoparticles Based on N,O-Carboxymethyl Chitosan-Dopamine Amide Conjugate for Nose-to-Brain Delivery
Trapani, A., Cometa, S., Giglio, E. D., Corbo, F., Cassano, R., Gioia, M. L. D., Trombino, S., Hossain, M. N., Gioia, S. D., Trapani, G., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010147 · Cited by 33
Exploiting mesoporous silica, silver and gold nanoparticles for neurodegenerative diseases treatment
Ribeiro, T. D. C., Sábio, R. M., Carvalho, G. C., Fonseca‐Santos, B., & Chorilli, M. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121978 · Cited by 33
In vitro Evaluation of Paliperidone Palmitate Loaded Cubosomes Effective for Nasal-to-Brain Delivery
Deruyver, L., Rigaut, C., Pérez, A. G., Lambert, P., Haut, B., & Goole, J. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s397650 · Cited by 33
Intranasal Carrier-Free Nanomodulator Addresses Both Symptomatology and Etiology of Alzheimer’s Disease by Restoring Neuron Plasticity and Reprogramming Lesion Microenvironment
Yang, W., Shi, Y., Zhang, Y., Yang, Y., Du, Y., Yang, Z., Wang, X., Lei, T., Xu, Y., Chen, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c09449 · Cited by 33
Intranasal Methylprednisolone Effectively Reduces Neuroinflammation in Mice With Experimental Autoimmune Encephalitis
Rassy, D., Bárcena, B., Pérez‐Osorio, I. N., Espinosa, A., Peón, A. N., Terrazas, L. I., Meneses, G., Besedovsky, H. O., Fragoso, G., & Sciutto, E. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz128 · Cited by 31
Emulsomes: new lipidic carriers for drug delivery with special mention to brain drug transport
Singh, S. R., Khurana, K., Chauhan, S. B., & Singh, I. (2023) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-023-00530-z · Cited by 30
Design of experiment (DoE) of mucoadhesive valproic acid-loaded nanostructured lipid carriers (NLC) for potential nose-to-brain application
Correia, A. C., Costa, I., Silva, R., Sampaio, P., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124631 · Cited by 30
Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition
Gorain, B., Rajeswary, D. C., Pandey, M., Kesharwani, P., Kumbhar, S. A., & Choudhury, H. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200313125613 · Cited by 31
First-line management of canine status epilepticus at home and in hospital-opportunities and limitations of the various administration routes of benzodiazepines
Charalambous, M., Volk, H. A., Ham, L. V., & Bhatti, S. F. M. (2021) · BMC Veterinary Research · doi:10.1186/s12917-021-02805-0 · Cited by 36
Quality-by-Design-Based Development of n-Propyl-Gallate-Loaded Hyaluronic-Acid-Coated Liposomes for Intranasal Administration
Sabir, F., Katona, G., Pallagi, E., Dobó, D. G., Akel, H., Berkesi, D. S., Kónya, Z., & Csóka, I. (2021) · Molecules · doi:10.3390/molecules26051429 · Cited by 30
Application of nanomaterials in diagnosis and treatment of glioblastoma
Yu, S., Chen, L., Xu, H., Long, S., Jiang, J., Wei, W., Niu, X., & Li, X. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.1063152 · Cited by 30
Advancement in the Nose-to-Brain Drug delivery of FDA-approved drugs for the better management of Depression and Psychiatric disorders
Upadhyay, R. K., Ghosh, P., & Desavathu, M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124866 · Cited by 31
A Pharmaco-Technical Investigation of Thymoquinone and Peat-Sourced Fulvic Acid Nanoemulgel: A Combination Therapy
Khan, R., Mirza, M. A., Aqil, M., Hassan, N., Zakir, F., Ansari, M. J., & Iqbal, Z. (2022) · Gels · doi:10.3390/gels8110733 · Cited by 30
Baclofen-Loaded Poly ( D , L -Lactide-Co-Glycolic Acid) Nanoparticles for Neuropathic Pain Management: In Vitro and In Vivo Evaluation
Nigam, K., Kaur, A., Tyagi, A., Manda, K., Gabrani, R., & Dang, S. (2018) · Rejuvenation Research · doi:10.1089/rej.2018.2119 · Cited by 28
Brain targeting of cefepime loaded transfersomes based thermosensitive in situ gel via intranasal delivery: In vitro and in vivo studies
Mirza, R., Khan, A. U., Shah, K. U., Ullah, N., Nawaz, A., Ghani, S. F., Javed, A., Shah, S. U., Alasmari, A. F., Alharbi, M., et al. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105585 · Cited by 28
Nose-to-brain Delivery of Biologics
Schwarz, B., & Merkel, O. M. (2019) · Therapeutic Delivery · doi:10.4155/tde-2019-0013 · Cited by 28
Long-acting therapeutic delivery systems for the treatment of gliomas
Padmakumar, S., & Amiji, M. M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114853 · Cited by 28
Bi-functional sterically hindered phenol lipid-based delivery systems as potential multi-target agents against Alzheimer's disease via an intranasal route
Burilova, E. A., Pashirova, T. N., Zueva, I. V., Гибадуллина, Э. М., Lushchekina, S. V., Sapunova, А. S., Kayumova, R. M., Rogov, A. M., Evtugyn, V. G., Sudakov, I. A., et al. (2020) · Nanoscale · doi:10.1039/d0nr04037a · Cited by 27
Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis
Mwema, A., Muccioli, G. G., & Rieux, A. D. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.052 · Cited by 27
Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration
Wu, H., Li, C., Yuan, H., Zhao, J., & Li, S. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s520768 · Cited by 26
Nose-to-brain delivery: A comparative study between carboxymethyl chitosan based conjugates of dopamine
Gioia, S. D., Trapani, A., Cassano, R., Gioia, M. L. D., Trombino, S., Cellamare, S., Bolognino, I., Hossain, M. N., Sanna, E., Trapani, G., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120453 · Cited by 27
Microemulsion as a promising carrier for nose to brain delivery: journey since last decade
Shah, B. M. (2021) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-021-00528-w · Cited by 26
Intranasal Paclitaxel Alters Alzheimer’s Disease Phenotypic Features in 3xTg-AD Mice
Cross, D. J., Huber, B. R., Silverman, M. A., Cline, M. M., Gill, T. B., Cross, C. G., Cook, D. G., & Minoshima, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210109 · Cited by 25
A Review of Techniques for Biodelivery of Nerve Growth Factor (NGF) to the Brain in Relation to Alzheimer’s Disease
Mitra, S., Gera, R., Linderoth, B., Lind, G., Wahlberg, L. U., Almqvist, P. M., Behbahani, H., & Eriksdotter, M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-74046-7_11 · Cited by 27
Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's
Hinge, N. S., Kathuria, H., & Pandey, M. M. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101303 · Cited by 25
Analytical and toxicological aspects of nanomaterials in different product groups: Challenges and opportunities
Tschiche, H. R., Bierkandt, F. S., Creutzenberg, O., Fessard, V., Franz, R., Greiner, R., Gruber‐Traub, C., Haas, K., Haase, A., Hartwig, A., et al. (2022) · NanoImpact · doi:10.1016/j.impact.2022.100416 · Cited by 27
Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose–Brain Drug Delivery
Taha, E., Shetta, A., Nour, S. A. E.-K., Naguib, M. J., & Mamdouh, W. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00588 · Cited by 26
Nanocarriers-mediated nose-to-brain drug delivery: A novel approach for the management of Alzheimer’s disease
Sonwani, A., Pathak, A., & Jain, K. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105855 · Cited by 25
The nasal route for nose-to-brain drug delivery: advanced nasal formulations for CNS disorders
Papakyriakopoulou, P., & Valsami, G. N. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2489553 · Cited by 29
Exploring Nose to Brain Nano Delivery for Effective Management of Migraine
Tanna, V., Sawarkar, S. P., & Ravikumar, P. (2022) · Current Drug Delivery · doi:10.2174/1567201819666220401091632 · Cited by 22
Tadpole-Like Anisotropic Polymer/Lipid Janus Nanoparticles for Nose-to-Brain Drug Delivery: Importance of Geometry, Elasticity on Mucus-Penetration Ability
Altas, B. O., Kalaycıoğlu, G. D., Lifshiz‐Simon, S., Talmon, Y., & Aydoğan, N. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00773 · Cited by 23
Intranasal delivery of phenytoin-loaded nanoparticles to the brain suppresses pentylenetetrazol-induced generalized tonic clonic seizures in an epilepsy mouse model
Yousfan, A., Rubio, N., Al‐Ali, M., Nattouf, A. H., & Kafa, H. (2021) · Biomaterials Science · doi:10.1039/d1bm01251g · Cited by 22
Intranasal Administration as a Route to Deliver Drugs to the Brain (Review)
Porfiryeva, N. N., Семина, И. И., Moustafine, R. I., & Khutoryanskiy, V. V. (2021) · Drug development & registration · doi:10.33380/2305-2066-2021-10-4-117-127 · Cited by 23
Enhancement in brain uptake of vitamin D3 nanoemulsion for treatment of cerebral ischemia: formulation, gamma scintigraphy and efficacy study in transient middle cerebral artery occlusion rat models
Kumar, M., Nishad, D. K., Kumar, A., Bhatnagar, A., Karwasra, R., Khanna, K., Keerthana, S. V., Sharma, D., Dua, K., Mudaliar, V., et al. (2020) · Journal of Microencapsulation · doi:10.1080/02652048.2020.1801870 · Cited by 21
Design and evaluation of nanostructured lipid carriers loaded with Salvia officinalis extract for Alzheimer's disease treatment
Markova, E., Taneska, L., Kostovska, M., Shalabalija, D., Mihailova, L., Dodov, M. G., Makreski, P., Geškovski, N., Petrushevska, M., Taravari, A. N., et al. (2022) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.35006 · Cited by 22
Nasal route for antibiotics delivery: Advances, challenges and future opportunities applying the quality by design concepts
Mardikasari, S. A., Sipos, B., Csóka, I., & Katona, G. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103887 · Cited by 22
Insight into central nervous system targeted nanostructured lipid carriers via the nose to brain pathway
Das, M., Sarma, A., Baruah, H., & Basak, D. (2024) · RSC Pharmaceutics · doi:10.1039/d4pm00057a · Cited by 23
Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration
Kadakia, E., Bottino, D. C., & Amiji, M. M. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2610-y · Cited by 20
Drug Delivery Systems and Strategies to Overcome the Barriers of Brain
Garg, Y., Kapoor, D. N., Sharma, A. K., & Bhatia, A. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612828666211222163025 · Cited by 21
PEGylated solid lipid nanoparticles for the intranasal delivery of combination antiretroviral therapy composed of Atazanavir and Elvitegravir to treat NeuroAIDS
Bazargani, A., Hejazi, M., Fernandez, M., Cordeiro, A., Ebode, J. T., Lewinski, N. A., da Rocha, S., & Golshahi, L. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125166 · Cited by 22
Lipid Nanoparticles Improve the Uptake of α-Asarone Into the Brain Parenchyma: Formulation, Characterization, In Vivo Pharmacokinetics, and Brain Delivery
Ramalingam, P., Ganesan, P., Prabakaran, D. S., Gupta, P. K., Jonnalagadda, S., Karthivashan, G., Revuri, V., Sivalingam, K., Sodha, S., Choi, D., et al. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01832-8 · Cited by 19
Cerebral ischemic stroke and different approaches for treatment of stroke
Girnar, G., & Mahajan, H. S. (2021) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-021-00289-1 · Cited by 19
Aldehyde-functional thermoresponsive diblock copolymer worm gels exhibit strong mucoadhesion
Brotherton, E. E., Neal, T. J., Kaldybekov, D. B., Smallridge, M. J., Khutoryanskiy, V. V., & Armes, S. P. (2022) · Chemical Science · doi:10.1039/d2sc02074b · Cited by 19
Carboxymethyl chitosan dopamine conjugates: Synthesis and evaluation for intranasal anti Parkinson therapy
Gioia, S. D., Fracchiolla, G., Cometa, S., Perna, F. M., Quivelli, A. F., Trapani, G., Daniello, V., Nobile, C., Hossain, M. N., Trapani, A., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127174 · Cited by 19
PLGA Nanoparticles Based Mucoadhesive Nasal In Situ Gel for Enhanced Brain Delivery of Topiramate
Tanna, V., Vora, A., Shah, P., Nair, A. B., Shah, J., & Sawarkar, S. P. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02917-4 · Cited by 19
Metal-organic frameworks for efficient drug adsorption and delivery
Hyjek, K., & Jodłowski, P. J. (2023) · Scientiae Radices · doi:10.58332/scirad2023v2i2a03 · Cited by 18
Challenges and Opportunities for Incorporating Physiological Information into Pharmacokinetic Models of Intranasal Drug Delivery to the Brain: A Review of the Current Status and Future Trajectories
Rezaee, S., Al‐Majdoub, Z. M., Galetin, A., Rostami‐Hodjegan, A., & Ogungbenro, K. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00297 · Cited by 19
Novel optimized biopolymer-based nanoparticles for nose-to-brain delivery in the treatment of depressive diseases
Sorrentino, A., Cataldo, A., Curatolo, R., Tagliatesta, P., Mosca, L., & Stefano Bellucci, A. (2020) · RSC Advances · doi:10.1039/d0ra04212a · Cited by 17
Development and Comparative In Vitro and In Vivo Study of BNN27 Mucoadhesive Liposomes and Nanoemulsions for Nose-to-Brain Delivery
Kannavou, M., Karali, K., Κάτσιλα, Θ., Siapi, E., Marazioti, A., Klepetsanis, P. G., Calogeropoulou, T., Charalampopoulos, I., & Antimisiaris, S. G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020419 · Cited by 16
Design and Characterization of pH Dependent Phase Transition System of Almotriptan Malate for Nasal Drug Delivery System by Employing Factorial Design
Malviya, V., & Pande, S. (2023) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.58.1.8 · Cited by 16
Hyaluronic Acid-Based Hybrid Nanoparticles as Promising Carriers for the Intranasal Administration of Dimethyl Fumarate
Serri, C., Piccioni, M., Guarino, V., Santonicola, P., Maya, I. C., Crispi, S., di Cagno, M. P., Ferraro, L., Dalpiaz, A., Botti, G., et al. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s481917 · Cited by 16
The Hypotonic Environmental Changes Affect Liposomal Formulations for Nose-to-Brain Targeted Drug Delivery
Wu, I. Y., Nikolaisen, T. E., Škalko‐Basnet, N., & di Cagno, M. P. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.03.006 · Cited by 16
Olfactory Drug Aerosol Delivery with Acoustic Radiation
Jamalabadi, M. Y. A., & Xi, J. (2022) · Biomedicines · doi:10.3390/biomedicines10061347 · Cited by 15
Brain targeting of drugs via intranasal route in conjunction with nanoparticle-based systems: an updated review
Furquan, A., Hafeez, A., & Rahman, M. A. (2023) · Journal of Nanoparticle Research · doi:10.1007/s11051-023-05880-6 · Cited by 17
Cubosomes: evolving platform for intranasal drug delivery of neurotherapeutics
Gawarkar‐Patil, P., Mahajan, B., Pawar, A., & Dhapte-Pawar, V. S. (2024) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-024-00665-7 · Cited by 19
Developments in the discovery and design of intranasal antidepressants
Panek, M., Kawalec, P., Pilc, A., & Lasoń, W. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1776697 · Cited by 17
Neuroinflammation in Alzheimer’s Disease: A Potential Role of Nose-Picking in Pathogen Entry via the Olfactory System?
Zhou, X., Kumar, P., Bhuyan, D. J., Jensen, S. O., Roberts, T. L., & Münch, G. W. (2023) · Biomolecules · doi:10.3390/biom13111568 · Cited by 17
Nanosized Intranasal Delivery of Novel Self-Assembled Cubic Liquid Crystals: Formulation and Evaluation
Desai, G. N., Dandagi, P. M., & Kazi, T. M. (2022) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-022-09695-1 · Cited by 14
Intranasal Lipid Nanoparticles Containing Bioactive Compounds Obtained from Marine Sources to Manage Neurodegenerative Diseases
Torres, J., Costa, I., Peixoto, A. F., Silva, R. V. D. S., Lobo, J. M. S., & Silva, A. C. (2023) · Pharmaceuticals · doi:10.3390/ph16020311 · Cited by 18
A CGRP receptor antagonist peptide formulated for nasal administration to treat migraine
von Mentzer, B., Russo, A. F., Zhang, Z., Kuburas, A., Killoran, P. M., D’Aloisio, V., Nižić, L., Capel, V., Kendall, D. A., Coxon, C. R., et al. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13317 · Cited by 15
The Encapsulation of Citicoline within Solid Lipid Nanoparticles Enhances Its Capability to Counteract the 6-Hydroxydopamine-Induced Cytotoxicity in Human Neuroblastoma SH-SY5Y Cells
Margari, A., Monteduro, A. G., Rizzato, S., Capobianco, L., Crestini, A., Rivabene, R., Piscopo, P., D’Onofrio, M., Manzini, V., Trapani, G., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091827 · Cited by 14
Modulation of olfactory area for effective transportation of actives in CNS disorders
Jain, H., Prabhakar, B. R., & Shende, P. K. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.103091 · Cited by 15
Advances and Strategies in Enhancing mRNA Cancer Vaccines
Zhang, M., Chen, S., Hu, H.-J., Ong, Y., & Ni, Q. (2025) · Advanced Materials · doi:10.1002/adma.202509880 · Cited by 17
The landscape of extracellular vesicles combined with intranasal delivery towards brain diseases
Li, J., Zhang, H., Jiang, Y., Li, N., Zhu, A., Zhang, Y., Feng, K., Zeng, W., Di, L., & Wang, R. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102169 · Cited by 15
Chitosan-coated nanoemulsion for the direct nose-to-brain delivery of sildenafil: Development and in vivo evaluation in a brain oxidative stress and inflammation model
Salama, A., Soliman, G. M., Elsherbiny, N. M., & Safwat, M. A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105842 · Cited by 14
Serum Albumin in Nasal Drug Delivery Systems: Exploring the Role and Application
Mardikasari, S. A., Katona, G., & Csóka, I. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101322 · Cited by 13
Chitosan-coated nanoemulsion for intranasal administration increases temozolomide mucosal permeation, cellular uptake, and In vitro cytotoxicity in glioblastoma multiforme cells
Duarte, J. L., Filippo, L. D. D., Vilella, K. J. A., Dutra, J. A. P., Ribeiro, D. M., da Silva, M. F., de Medeiros, A. I., & Chorilli, M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106390 · Cited by 13
A narrative review on potential applications of spanlastics for nose-to-brain delivery of therapeutically active agents
Nadim, N., Khan, A. A., Khan, S. M., Parveen, R., & Ali, J. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103341 · Cited by 13
Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery
de Barros, C. T., Rios, A. C., Alves, T., Batain, F., Crescencio, K., Lopes, L. J., Zielińska, A., Severino, P. B., Mazzola, P. G., Souto, E. B., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175974 · Cited by 15
Direct transport theory: From the nose to the brain
Dhas, N. L., Yadav, D., Singh, A. K., Garkal, A., Kudarha, R. R., Bangar, P., Savjani, J., Pardeshi, C. V., Garg, N., & Mehta, T. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00001-1 · Cited by 13
Challenges in the Development and Application of Organ-on-Chips for Intranasal Drug Delivery Studies
Khan, M. U., Cai, X., Shen, Z., Mekonnen, T. T., Kourmatzis, A., Cheng, S., & Gholizadeh, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051557 · Cited by 14
A Computational Systems Approach to Rational Design of Nose-to-Brain Delivery of Biopharmaceutics
Kiparissides, C. A., Vasileiadou, A. C., Karageorgos, F. F., & Serpetsi, S. K. (2019) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.9b04885 · Cited by 13
Self-citation
Harmony of T cell profile in brain, nasal, spleen, and cervical lymph nodes tissues in Alzheimer’s: A systemic disease with local manifestations
Pakravan, N., Abbasi, A., Basirat, E., Dehghan, D., & Havadaragh, S. H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107306 · Cited by 12
Advancements in nose-to-brain drug targeting for Alzheimer’s disease: a review of nanocarriers and clinical insights
Komal, K., Ghosh, R., Sil, D., Sharma, R., Kumar, S., Pandey, P., & Kumar, M. (2025) · Inflammopharmacology · doi:10.1007/s10787-024-01636-3 · Cited by 15
Intranasal gene therapy for the treatment of neurological disorders
Dhas, N. L., Mehta, T. A., Sharma, S., Garkal, A., Yadav, D., Hariharan, K., Shamjetshabam, B., Khot, S. V., Kudarha, R. R., Bangar, P., et al. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00017-5 · Cited by 13
Intranasal administration of innovative triamcinolone acetonide encapsulated cubosomal in situ gel: formulation and characterization
Patil, R., Patil, A. S., Chougule, K. R., Gaude, Y., & Masareddy, R. S. (2023) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2023.2297275 · Cited by 11
Development of nanostructured environmentally responsive system containing hydroxypropyl methylcellulose for nose-to-brain administration of meloxicam
Botan, M. V. G., da Silva, J. B., & Bruschi, M. L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130015 · Cited by 11
Nanocarrier Mediated Intranasal Drug Delivery Systems for the Management of Parkinsonism: A Review
Kapoor, A., Hafeez, A., & Kushwaha, P. (2023) · Current Drug Delivery · doi:10.2174/1567201820666230523114259 · Cited by 10
Nanostructure self-assembly for direct nose-to-brain drug delivery
Chaud, M. V., Rios, A. C., dos Santos, C. A., de Barros, C. T., de Souza, J. F., & Alves, T. F. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817998-7.00019-7 · Cited by 11
Advances in nanocarrier-based nose-to-brain drug delivery systems for neurological disorders - A comprehensive review
Kamyab, H., Jamalpour, S., Khalili, E., & Rajendran, S. (2026) · Powder Technology · doi:10.1016/j.powtec.2026.122244 · Cited by 13

Authors: Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C.
Affiliations: Aristotle University of Thessaloniki (GR)
Centre for Research and Technology Hellas (GR)
Corresponding author: Kiparissides, Costas
ORCID: Bourganis, Vassilis
Kammona, Olga
Alexopoulos, Aleck
Kiparissides, Costas
Venue: European Journal of Pharmaceutics and Biopharmaceutics
Publisher: Elsevier BV
Published: 2018-07
Volume: 128
Pages: 337-362
ISSN: 0939-6411 (ISSN-L)
DOI: 10.1016/j.ejpb.2018.05.009
OpenAlex: W2801808920
Cited by: 357
References: 219
Citations by year: 2026: 31 · 2025: 39 · 2024: 52 · 2023: 61 · 2022: 53 · 2021: 54 · 2020: 38 · 2019: 23 · 2018: 6
FWCI: 2.63
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: European Journal of Pharmaceutics and Biopharmaceutics (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: European Framework Programme for Research and Innovation Horizon 2020 (721098)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: nose-to-brain delivery, blood-brain barrier, brain drug delivery, central nervous system disorders, multiple sclerosis, Alzheimer's disease, intranasal drug delivery
MeSH terms: Administration, Intranasal, Animals, Biological Transport, Blood-Brain Barrier, Brain, Central Nervous System Agents, Central Nervous System Diseases, Drug Carriers, Epithelium, Humans, Nasal Mucosa, Permeability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks